• ProBioGen Appoints CEO contractpharma
    May 04, 2020
    ​ProBioGen AG, a Berlin-based contract development and manufacturing organization (CDMO) for developing and manufacturing complex therapeutic glycoproteins, has appointed Dr. Lutz Hilbrich as chief executive officer, effective June 1, 2020.
PharmaSources Customer Service